Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.
Bone Marrow Transplant. 2013 Nov;48(12):1537-42. doi: 10.1038/bmt.2013.98. Epub 2013 Jul 15.
Bone Marrow Transplant. 2013.
PMID: 23852321
Free PMC article.
Clinical Trial.
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial.
Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC.
Sanchorawala V, et al.
Blood. 2007 Jan 15;109(2):492-6. doi: 10.1182/blood-2006-07-030544. Epub 2006 Sep 7.
Blood. 2007.
PMID: 16960148
Free article.
Clinical Trial.
Item in Clipboard
High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.
Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V.
Seldin DC, et al.
Amyloid. 2011 Jun;18 Suppl 1(Suppl 1):127-9. doi: 10.3109/13506129.2011.574354047.
Amyloid. 2011.
PMID: 21838459
Free PMC article.
Item in Clipboard
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V.
Seldin DC, et al.
Clin Lymphoma. 2003 Mar;3(4):241-6. doi: 10.3816/clm.2003.n.005.
Clin Lymphoma. 2003.
PMID: 12672274
Clinical Trial.
Item in Clipboard
Kidney dysfunction during lenalidomide treatment for AL amyloidosis.
Specter R, Sanchorawala V, Seldin DC, Shelton A, Fennessey S, Finn KT, Zeldis JB, Dember LM.
Specter R, et al.
Nephrol Dial Transplant. 2011 Mar;26(3):881-6. doi: 10.1093/ndt/gfq482. Epub 2010 Aug 5.
Nephrol Dial Transplant. 2011.
PMID: 20693160
Free PMC article.
Item in Clipboard
Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis.
Sanchorawala V, Finn KT, Fennessey S, Shelton A, Doros G, Zeldis JB, Seldin DC.
Sanchorawala V, et al.
Blood. 2010 Sep 16;116(11):1990-1. doi: 10.1182/blood-2010-07-295485.
Blood. 2010.
PMID: 20847211
Free article.
No abstract available.
Item in Clipboard
Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.
Tapan U, Seldin DC, Finn KT, Fennessey S, Shelton A, Zeldis JB, Sanchorawala V.
Tapan U, et al.
Blood. 2010 Dec 2;116(23):5071-2. doi: 10.1182/blood-2010-09-305136.
Blood. 2010.
PMID: 21127185
Free article.
No abstract available.
Item in Clipboard
Cite
Cite